Androgen Receptor Modulator Compounds Specificity Efficacy

The patent applies parameter changes by systematically modifying chemical structure parameters of SARM compounds. Multiple formula variants (I-VI) are presented with different substituent groups (R1-R26) including halogens, alkyl groups, heteroalkyl groups, and functional groups at various positions. This structural parameter optimization enables enhanced receptor specificity while maintaining or improving therapeutic efficacy across different conditions.

The patent employs composite material principles by creating complex molecular structures that combine multiple functional groups and structural elements within single SARM compounds. The compounds integrate aromatic rings, heterocyclic groups, alkyl chains, and various functional moieties (carbonyl, hydroxyl, amino groups) to achieve both high specificity for androgen receptors and broad efficacy for treating muscle loss, bone density issues, and hormonal imbalances.

The patent applies segmentation by dividing the complex SARM molecule into distinct functional segments or domains. Each formula (I-VI) shows a core structure with multiple substitutable positions (R1 through R26) that can be independently optimized. This modular approach allows chemists to systematically build complexity by selecting specific combinations of substituent groups rather than designing entire molecules from scratch, thereby managing complexity while achieving high specificity.

The patent implements local quality by allowing different regions of the SARM molecule to have specialized functions through localized substituent groups. Specific R groups at different positions can be tailored to enhance binding affinity, selectivity, or metabolic stability without affecting the entire molecule. For example, halogen substituents at aromatic positions may enhance binding specificity while alkyl chains at other positions may improve membrane permeability, enabling localized optimization of different molecular properties.